The very high incidence of cervical cancer in Northern Territory Indigenous women has fallen by half since the early 1990s, partly as a result of increased participation in Pap Test screening, according to new research published by the Menzies School of Health Research (MSHR) and the NT Department of Health and Community Services (DHCS).
Researchers at the UCLA Henry Samueli School of Engineering and Applied Science today announced they have developed a new reverse osmosis (RO) membrane that promises to reduce the cost of seawater desalination and wastewater reclamation.
“Medicine alone is not enough to get you through cancer,” comments Linda Dibblee, breast cancer survivor and winner of the 2006 Lilly Oncology on Canvas International Art Competition and Exhibition. “You have to stay strong and positive through even the darkest times. Having a channel through which you can release your feelings can help you find strength that you never knew you had. For me, painting became my way of expressing all my thoughts, hopes and frustrations, and I truly believe it played a part in helping me beat cancer.”
ImClone Systems Incorporated (NASDAQ:IMCL) and Bristol-Myers Squibb Company (NYSE:BMY) today announced results from two randomized Phase III trials of ERBITUX(R) (cetuximab) in patients with metastatic colorectal cancer. These are the first large, randomized studies to examine the impact of ERBITUX treatment on overall survival in colon cancer.
Novartis announced today that Prexige? (lumiracoxib), an oral selective COX-2 inhibitor anti-inflammatory drug, has been cleared for approval in the European Union as a new treatment option for patients suffering from osteoarthritis. This is the most common form of arthritis and a leading cause of chronic pain[2].
GlaxoSmithKline (NYSE: GSK) and Adolor Corporation (Nasdaq: ADLR) announced that the Food and Drug Administration (FDA) has issued a letter stating that the new drug application (NDA) for Entereg (alvimopan 12mg) for the management of post operative ileus (POI) is approvable. The FDA has requested 12-month safety data, including analysis of serious cardiovascular events, from study 014 (767905/014), an ongoing safety study in opioid-induced bowel dysfunction (OBD). The FDA also requested a risk management plan as part of the submission.
People who experience a pounding heart, sweaty palms or dizziness — even if the cause is something as mundane as stress, exercise or caffeine — are more likely to develop a clinical case of anxiety or panic disorder, according to a Florida State University researcher in Tallahassee, Fla.
Ear infections are among the most common diseases seen in pediatric practice. They have generally been considered bacterial diseases and are therefore usually treated with antibiotics. New research, published in the Dec. 15 issue of Clinical Infectious Diseases and currently available online, provides evidence that viruses are found in a great many ear infection cases and may complicate treatment.
A study recently published in Hemodialysis International found that more frequent hemodialysis treatments (five or more weekly) can significantly increase the survival rate of patients suffering from irreversible kidney failure. Typical treatment in the US generally involves three sessions weekly.
Researchers at the UCLA Henry Samueli School of Engineering and Applied Science today announced they have developed a new reverse osmosis membrane that promises to reduce the cost of seawater desalination and wastewater reclamation.